First News

Growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth. What the Market Looks Like? Predicted to grow at a CAGR of 7.4 % during the forecast period, the global  dental biomaterials market  is estimated to reach USD 9.6 Billion by the end of 2023. In 2018, Europe held the largest share of this market, and this is primarily attributed to the growing geriatric population, increasing government expenditure on oral healthcare, higher adoption of the dental biomaterials to manufacture implants and other dental products, and growing number of dental hospitals and clinics. Market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the largest ...

The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. The increasing prevalence of dental disorders, rising geriatric population, growing dental tourism in developing countries, and increasing disposable income are the major factors driving the growth of this market. On the other hand, stringent regulatory and clinical processes are expected to restrain market growth to a certain extent. The global dental biomaterial market is consolidated at the top with the presence few big players in the market. However, there are many local, regional, and global players operating in this market, making it highly competitive. Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, In...